Brad Fugere

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

UAMS

Also affiliated: University of Arkansas Medical Center (2025); Central Arkansas Veterans Healthcare System (2023)

Unknown Researcher

1 h-index 9 pubs 1 cited

Research Areas

OverviewAI-generated summary

Brad Fugere's research focuses on investigating real-world cardiovascular outcomes across various patient populations and therapeutic interventions. His work includes examining the association between cardiovascular outcomes in individuals undergoing percutaneous coronary intervention, with or without preceding coronary CT angiography. He has also studied the cardiovascular outcomes of combined SGLT2 inhibitor and GLP1 receptor agonist therapy in individuals with type 2 diabetes, as well as the outcomes of GLP-1RA therapy in obese non-diabetic patients with metabolic dysfunction-associated steatotic liver disease. Further research includes comparing the real-world cardiovascular outcomes of Inclisiran versus PCSK9 monoclonal antibodies in individuals with hyperlipidemia and evaluating the cardioprotective effect of beta-blocker therapy post-myocardial infarction. Fugere has also explored outcomes related to CAR-T therapy in relapsed/refractory DLBCL and patient characteristics for rare dendritic cell neoplasms. His collaborations include work with researchers Jim Zhongning Chen, Liyan Mazahreh, Farah Mazahreh, and Mamatha Gaddam at the University of Arkansas for Medical Sciences.

Metrics

h-index: 1
Publications: 9
Citations: 1

Selected Publications

Examining the association between cardiovascular outcomes in individuals undergoing percutaneous coronary intervention with or without a preceding coronary CT angiogram (2026)

European Heart Journal - Imaging Methods and Practice 1 citation DOI OpenAlex
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)

Journal of the American College of Cardiology DOI OpenAlex
26-A-15959-ACC CARDIOVASCULAR OUTCOMES OF GLP-1RA THERAPY IN OBESE NON-DIABETIC PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A REAL-WORLD ANALYSIS (2026)

Journal of the American College of Cardiology DOI OpenAlex
1200.03 Real-World Cardiovascular Outcomes of Inclisiran Versus PCSK9 Monoclonal Antibodies Therapy in Individuals with Hyperlipidemia (2026)

JACC: Cardiovascular Interventions DOI OpenAlex
Impact of Response to Bridging Therapy on Outcomes of CAR-T Therapy in Relapsed/Refractory DLBCL: A Single Center Retrospective Analysis (2024)

Blood DOI OpenAlex
Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms (2023)

Blood DOI OpenAlex